Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros

Base de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Cancer Surviv ; 2024 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-38512563

RESUMEN

PURPOSE: To identify risk factors of chemotherapy-related cognitive impairment (CRCI) and construct and validate a visual prediction model of such for patients with breast cancer. METHODS: A multicenter, descriptive, and cross-sectional design was adopted. Data were collected from ten public tertiary hospitals in China. Cognitive function was assessed by using Functional Assessment of Cancer Therapy-cognitive function. Socio-demographic, clinical, psychological, and physical indicators were also assessed. The logistic prediction model was constructed by fivefold cross-validation. Then, a nomogram was utilized to visualize the prediction model, which was also evaluated via discrimination, calibration, and decision curve analysis. RESULTS: A total of 71 breast cancer patients had CRCI with a prevalence of 9.58%. This visual prediction model was constructed based on education background, exercise frequency, chemotherapy times, and fatigue and demonstrated good discrimination, with an area under the receiver operating characteristic curve of 0.882. The calibration curve indicated good agreement between experimental and projected values, and the decision curve proved good clinical applicability. CONCLUSION: Education background, exercise frequency, chemotherapy times, and fatigue were associated with high incidence of CRCI. The prediction model exhibits superior performance and has promise as a useful instrument for assessing the likelihood of CRCI in breast cancer patients. IMPLICATIONS FOR CANCER SURVIVORS: Our findings could provide breast cancer survivors with risk screening based on CRCI predictors to implement prevention and early intervention, and help patients integrate into society and achieve comprehensive recovery.

2.
Sci Total Environ ; 915: 169802, 2024 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-38215839

RESUMEN

In scenarios involving sudden releases of unidentified gases or concealed pollution emergencies, source control emerges as a critical procedure to safeguard residential air quality. Appropriate inverse source tracking methodology depending on diverse measurement data could be utilized to promptly identify pollutant source parameters. In this study, source term estimation (STE) method, i.e., jointly combining probability adjoint method with the Bayesian inference method, has been proposed. General form of the pollutant inverse transport equation was firstly established. Subsequently, the pollution source information, assumed from single continuous point releases during Fusion Field Trials 2007 under an unsteady wind field, was identified using the Bayesian inference probability adjoint inverse method. Metropolis-Hastings Markov Chain Monte Carlo (MH-MCMC) and Differential Evolution Markov Chain Monte Carlo (DE-MCMC) were then compared as sampling methods for Bayesian inference. Results indicated that the DE-MCMC algorithm has superior convergence and could present higher accuracy of pollutant source information than that of MH-MCMC algorithm, particularly for highly nonlinear and multi-modal distribution systems. Furthermore, the integration of Union standard Adjoint Location Probability (UALP) as prior information into the Bayesian inference probability adjoint inverse method effectively narrowed the sampling range, enhancing both the accuracy and robustness of the proposed approach. Finally, the impact of the covariance matrix on the inverse identification accuracy was explored. Overall, this research has provided insights into the future applicability of this Bayesian inference inversion technique for point source identification.

3.
Support Care Cancer ; 32(2): 98, 2024 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-38200265

RESUMEN

PURPOSE: Breast cancer survivors face dual challenges: long-term sequelae of treatment and the risk of recurrent disease. Furthermore, obesity and a sedentary lifestyle can complicate both challenges. We aimed to assess the effect of a 12-week exercise-based weight-management program in overweight/obese breast cancer survivors. METHODS: A two-arm, single-blinded, randomized controlled trial was conducted among 60 overweight/obese, stage 0-III breast cancer survivors. During the 12-week program, the intervention group received weekly information support, fortnightly exercise prescriptions, including aerobic and resistance exercises to perform at home, and one dietary instruction. The control group received information support about weight management and exercise. Weight, body composition, and physical fitness data were collected at baseline, postintervention, and the 3-month follow-up. RESULTS: The intervention group showed significant improvements in body weight and all adiposity indices, including body mass index, waist circumference, and %body fat, in comparison with baseline (P < 0.001) and the control group (P < 0.05). Both groups showed no significant changes in fat-free mass during the 6-month period (P > 0.05). International Physical Activity Questionnaire scores and left grip strength increased significantly in the intervention group in comparison with the baseline (P < 0.01) and the control group (P < 0.05). Right grip strength, lower-body strength, and aerobic endurance showed no significant intergroup differences (P > 0.05). CONCLUSIONS: A combination of exercise prescription and weight-loss interventions yielded clinically meaningful weight loss in overweight/obese breast cancer survivors. These findings may facilitate the incorporation of home-based exercise and weight management into breast cancer treatment and survivorship care.


Asunto(s)
Carcinoma de Mama in situ , Neoplasias de la Mama , Supervivientes de Cáncer , Humanos , Femenino , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/terapia , Sobrepeso/terapia , Mama , Obesidad/terapia
4.
Sci Total Environ ; 851(Pt 1): 158053, 2022 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-35985601

RESUMEN

In the present work, a delicate CFD research of a multi-street canyon model with varying thermal stratifications and non-uniformities of buildings was conducted to investigate the street ventilation and pollutant dispersion between the compact urban blocks. Non-isothermal turbulent wind flow, temperature field and pollutant dispersion in a two-dimensional computational domain were solved by the Renormalization Group (RNG) k-ε turbulence model along with the enhanced wall treatment. Present numerical results indicated that the variation of ground heating intensity has a significant influence on the airflow pattern in the step-down case, and the distribution of pollutants in the street canyons mainly depends on the variation of the upper clockwise vortex. The canyon ventilation performance became better as the unstable thermal stratification strengthened. Similarly, the increase of ground heating intensity could reduce ADF (atmospheric dispersion factor) in the step-down case and ADF became the lowest when Ri = -3.92 was maintained. Additionally, the increase of building unevenness further complicated the canyon airflow structure, which aggravated the pollution of the canyon. In the step-down configuration, as the standard deviation of adjacent building height gradually increases, canyon ventilation could be further enhanced. For the step-up configuration, the best ventilation performance was found at σH = 16.7 %. ADF of adjacent canyons also varied greatly. When σH = 33.3 % was maintained, the peak and bottom values of ADF were discovered in the step-up and step-down cases, respectively. Present research has provided a theoretical reference for guiding urban design and improve living environment in modern compact cities.


Asunto(s)
Contaminantes Atmosféricos , Contaminantes Ambientales , Contaminantes Atmosféricos/análisis , Ciudades , Modelos Teóricos , Emisiones de Vehículos/análisis , Viento
5.
Sci Total Environ ; 722: 137924, 2020 Jun 20.
Artículo en Inglés | MEDLINE | ID: mdl-32208270

RESUMEN

Periodic vortex shedding around a building could play an important role in wind-driven single-sided ventilation especially when two free openings are mounted on the leeward wall, in which case "pumping" flow dominates the natural ventilation. In this paper, we investigated the characteristics of vortex shedding and "pumping" flow affected by the arrangements of upstream buildings and opening area ratio of ports on the downstream target building. Computational fluid dynamics (CFD) simulations have been used to predict the instantaneous and mean flow fields. Numerical results indicate that the strength of "pumping" flow could be intensively weakened by two upstream buildings. Vortex shedding from the inner shear layers dominates the vortex shedding from the target building and constrains that from both upstream buildings except at W/B = 0.5, in which case the gap flow is weak and the St is close to that of a single building. The increase of upstream building length leads to decrease of the vortex shedding frequency at the wake of all buildings and ventilation rate of the downstream building. An increase of opening area ratio on the rear wall of the downstream building will raise the Strouhal number but have no positive correlation with ventilation rate. "Pumping" flow oscillating frequency does not have clear correlation with the ventilation rate. Our study on the wake vortex shedding flow across building clusters could benefit the future green design of urban buildings.

6.
Sci Total Environ ; 565: 1102-1115, 2016 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-27262984

RESUMEN

The pedestrian level pollutant transport in street canyons with multiple aspect ratios (H/W) is numerically investigated in the present work, regarding of various unstable thermal stratification scenarios and plain surrounding. Non-isothermal turbulent wind flow, temperature field and pollutant spread within and above the street canyons are solved by the realizable k-ε turbulence model along with the enhanced wall treatment. One-vortex flow regime is observed for shallow canyons with H/W=0.5, whereas multi-vortex flow regime is observed for deep canyons with H/W=2.0. Both one-vortex and multi-vortex regimes could be observed for the street canyons with H/W=1.0, where the secondary vortex could be initiated by the flow separation and intensified by unstable thermal stratification. Air exchange rate (AER) and pollutant retention time are adopted to respectively evaluate the street canyon ventilation and pollutant removal performance. A second-order polynomial functional relationship is established between AER and Richardson number (Ri). Similar functional relationship could be established between retention time and Ri, and it is only valid for canyons with one-vortex flow regime. In addition, retention time could be prolonged abruptly for canyons with multi-vortex flow regime. Very weak secondary vortex is presented at the ground level of deep canyons with mild stratification, where pollutants are highly accumulated. However, with the decrease of Ri, pollutant concentration adjacent to the ground reduces accordingly. Present research could be applied to guide the urban design and city planning for enhancing pedestrian environment.


Asunto(s)
Movimientos del Aire , Contaminantes Atmosféricos/análisis , Planificación Ambiental , China , Ciudades , Monitoreo del Ambiente , Hidrodinámica , Modelos Teóricos , Temperatura , Ventilación , Viento
7.
Head Face Med ; 7: 11, 2011 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-21736714

RESUMEN

OBJECTIVE: To examine the effects of bleomycin A5 on infantile maxillofacial haemangiomas. METHODS: Bleomycin A5 was given by multiple intralesinoal injections and the dosage was given according to the age of the patient and size of the lesion. Parts of patients were accompanied by prednisone treatment (2-5 mg/kg, po, QOD. RESULTS: All the haemangiomas involutes completely after treated with bloemycin A5 with better recovery of skin color and less scar forming in small haemangiomas. CONCLUSION: Infantile haemangioma could be effectively treated with bleomycin A5 without serious side effects.


Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Bleomicina/análogos & derivados , Neoplasias Faciales/tratamiento farmacológico , Hemangioma/tratamiento farmacológico , Neoplasias Maxilares/tratamiento farmacológico , Bleomicina/administración & dosificación , Relación Dosis-Respuesta a Droga , Neoplasias Faciales/diagnóstico , Femenino , Hemangioma/diagnóstico , Humanos , Lactante , Recién Nacido , Inyecciones Intralesiones , Imagen por Resonancia Magnética , Masculino , Neoplasias Maxilares/diagnóstico , Estudios Retrospectivos , Resultado del Tratamiento
8.
Zhonghua Kou Qiang Yi Xue Za Zhi ; 44(3): 162-4, 2009 Mar.
Artículo en Chino | MEDLINE | ID: mdl-19576022

RESUMEN

OBJECTIVE: To investigate the feasibility of establishing a murine hemangioma model with injection of recombinant adeo-associated virus mediated human vascular endothelial growth factor-121 (rAAV-hVEGF(121)) gene. METHODS: rAAV-hVEGF(121) was constructed, identified and then implanted to the left back ear of each mouse (1.0 x 10(11)VG in 50 microl per mouse and 10 nude mice received the injection), the rights served as controls with an injection of the same volume of phosphate buffered solution (PBS). The skin color and swelling of left back ear were observed every other day. Histological examination was carried out after mice were sacrificed 2, 4, 6, 8, 12 weeks after injection. RESULTS: The rAAV-hVEGF(121) was correctly constructed and confirmed by restriction endonuclease analysis, polymerase chain reaction and DNA sequencing analysis. The skin of left back ear became red 2 weeks after injection and gradually exhibited a red lump which was at its utmost 12 weeks after injection. Such phenomena were not observed in right back ear. Histological examinations showed aggregates of endothelial cells by 2 weeks and at 8 weeks the swollen tissue contained many cysts filled with a mass of red cells. CD-34 staining suggested most of the newly-formed cells were endothelial cells. CONCLUSIONS: A hemangioma model was established in mice with injection of recombinant rAAV-hVEGF(121) gene.


Asunto(s)
Dependovirus/genética , Modelos Animales de Enfermedad , Vectores Genéticos , Hemangioma , Factor A de Crecimiento Endotelial Vascular/genética , Animales , Femenino , Humanos , Ratones , Ratones Desnudos
9.
Beijing Da Xue Xue Bao Yi Xue Ban ; 41(1): 21-7, 2009 Feb 18.
Artículo en Chino | MEDLINE | ID: mdl-19221558

RESUMEN

Vascular birthmarks are the most common disease. The morbidity is about 2.5%, most of the lesions occur in oral and maxillofacial regions which accounts for 40%-60% of the total lesions. In 1982, Mulliken and Glowacki proposed a biologic classification of vascular birthmarks on the basis of their clinical manifestations, histopathological features, and natural history. They defined hemangiomas as vascular tumors with a growth phase, marked by endothelial proliferation and hypercellularity, and an involutional phase. They recognized that many entities referred to as hemangiomas are actually structural malformations of the vasculature, derived from capillaries, veins, lymph vessels, or arteries or from a combination of these sources. The classification was confirmed and issued by International Society for the study of vascular anomaly (ISSVA) in 1988. Waner and Suen amended the above category in 1995. This paper presents the new classification of vascular birthmarks and the developments in this field in recent years, including the pathology, clinical features and the therapy. For example, the classification of venular malformation categorized by Waner in 1989; the classification of lymphous malformation by Waner and Suen in 1995; and the treatments according to above classifications.


Asunto(s)
Hemangioma/clasificación , Neoplasias Cutáneas/clasificación , Malformaciones Vasculares/clasificación , Hemangioma/diagnóstico , Hemangioma/terapia , Humanos , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/terapia , Malformaciones Vasculares/diagnóstico , Malformaciones Vasculares/terapia
10.
Beijing Da Xue Xue Bao Yi Xue Ban ; 41(1): 105-8, 2009 Feb 18.
Artículo en Chino | MEDLINE | ID: mdl-19221576

RESUMEN

OBJECTIVE: Investigated the efficacy of Avastin on murine hemangioendothelioma in vitro and in vivo using a mouse hemangioendothelioma-derived cell line----EOMA. METHODS: The in vitro effect of Avastin on cell proliferation of EOMA cell line was measured by CCK-8 assay at 0, 50, 100, 200 mg/L concentration of Avastin. When tumors produced by subcutaneous injection of EOMA cells reached a volume of 100 mm(3), animals were treated by intra-tumor injection with Avastin (1 mg/kg body weight) or with vehicle alone (PBS) twice a week. Mice were weighted and tumors were measured three times weekly. At the end of the experiment, the mice were sacrificed and their tumors were excised and processed for histology. Immunohistochemical study of apoptosis was conducted using a TUNEL kit, tumor cell proliferation was assessed with anti-proliferating cell nuclear antigen (PCNA) antibody. Cardiac puncture was performed under deep anesthesia for collection of serum, serum vascular endothelial growth factor (VEGF) level was tested by VEGF-ELISA assay. RESULTS: Avastin exhibited cell inhibited rate of 24.21%, 26.26% and 34.58% at 50, 100 and 200 mg/L, respectively. When experiment was terminated, the tumor volume in the PBS-treated mice was (1 860.10+/-146.96) mm3, being significantly larger than that in the mice that were treated by Avastin [(681.45+/-63.01) mm3, P<0.01]. Avastin-treated tumors showed decreased tumor cell proliferation and increased cell apoptosis. The VEGF level in mice treated with Avastin [(594.65+/-118.79) ng/L] was significantly lower than that in PBS-treated mice [(802.24+/-238.41) ng/L, P<0.05]. CONCLUSION: The results suggest that topically applied Avastin provides an effective and safe approach to treat hemangioendotheliomas and might be used as a novel treatment of angiomatous diseases in the future.


Asunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Hemangioendotelioma/tratamiento farmacológico , Hemangioendotelioma/patología , Neoplasias Cutáneas/tratamiento farmacológico , Inhibidores de la Angiogénesis/farmacología , Animales , Anticuerpos Monoclonales/farmacología , Anticuerpos Monoclonales Humanizados , Bevacizumab , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Femenino , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Trasplante de Neoplasias , Neoplasias Cutáneas/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA